Andrew Conrad
Earned a PhD in cell biology from UCLA, then co-founded the National Genetics Institute (NGI) in 1991, a clinical diagnostics lab specializing in blood screening for HIV and hepatitis. After NGI was acquired by LabCorp, Conrad served as its Chief Scientific Officer. He joined Google X in 2012 to launch what became Verily (originally Google Life Sciences), spinning it out as an independent Alphabet subsidiary in 2015. His prior work running a high-throughput diagnostics lab directly informed Verily's thesis: that healthcare needed a data-operating system, not just another biotech. Throughout his tenure, Conrad cultivated a reputation as a demanding, compulsive leader — a style that STAT News and others linked to significant executive turnover during Verily's early years.







